Smoflipid: payments to doctors
Payments that named Smoflipid as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $551K
- Providers
- 453
- Transactions
- 1,320
- Average per transaction
- $418
The per-transaction average — $418 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 453 providers the average total is $1,217, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Fresenius Kabi USA, LLC | $551,185 | 100.0% |